In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales

In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales

Objective. To evaluate in vitro activity of biapenem and other clinically available carbapenems against Russian clinical isolates of Enterobacterales, Pseudomonas aeruginosa и Acinetobacter spp., including isolates with acquired fermentative mechanisms of resistance to β-lactams. Materials and Me...

Full description

Bibliographic Details
Main Authors:	Kozlov R.S., Azyzov I.S., Dekhnich A.V., Ivanchik N.V., Kuzmenkov A.Yu., Martinovich А.А., Mikotina A.V., Sukhorukova M.V., Trushin I.V., Edelstein M.V.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2021-09-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	biapenem carbapenems meropenem imipenem ertapenem enterobacterales pseudomonas acinetobacter
Online Access:	https://cmac-journal.ru/publication/2021/3/cmac-2021-t23-n3-p280/cmac-2021-t23-n3-p280.pdf

Similar Items

Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis
by: Po-Yu Huang, et al.
Published: (2023-06-01)

Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
by: Brendan Mackay, et al.
Published: (2022-10-01)

Overview and Insights into Carbapenem Allergy
by: Yuman Lee, et al.
Published: (2019-08-01)

Pharmacokinetics of biapenem in critically ill patients
by: Zyryanov S.K., et al.
Published: (2023-09-01)

Detection of mcr-1-mediated resistance to polymyxins in Enterobacterales using colistin disk chelator application
by: Azyzov I.S., et al.
Published: (2022-09-01)

Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008–2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART)
by: Shio-Shin Jean, et al.
Published: (2020-06-01)

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
by: Isha Pahuja, et al.
Published: (2023-08-01)

The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
by: Chiaki Ikenoue, et al.
Published: (2024-02-01)

The Comparison of Various Antibiotics Sensitivities in Uropathogen Escherichia coli Strains Producing Community and Hospital-Acquired Extended Spectrum Beta-Lactamase
by: Şafak ÖZER BALİN, et al.
Published: (2015-06-01)

Antimicrobal resistance of nosocomial carbapenemase-producing Enterobacterales in Russia: results of surveillance, 2014-2016
by: Shajdullina E.R., et al.
Published: (2018-11-01)

Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2
by: Anka Lucic, et al.
Published: (2022-03-01)

Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China
by: Yinping Wang, et al.
Published: (2024-12-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis
by: Xuemei Tao, et al.
Published: (2022-11-01)

Phenotypic Detection of Metallo-beta-lactamase in Clinical Isolates of Pseudomonas aeruginosa
by: Armindo José Perozo Mena, et al.
Published: (2012-07-01)

Detección fenotípica de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa
by: Perozo-Mena Armindo José, et al.
Published: (2012-12-01)

Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an Icu of a Tertiary Care Hospital
by: Sonika Agarwal, et al.
Published: (2017-01-01)

Diverse Role of <i>bla</i><sub>CTX-M</sub> and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales
by: Cody A. Black, et al.
Published: (2024-02-01)

Antimicrobial resistance of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
by: Edelstein M.V., et al.
Published: (2017-02-01)

Mechanism for transmission and pathogenesis of carbapenem-resistant Enterobacterales harboring the carbapenemase IMP and clinical countermeasures
by: Chengru Yang, et al.
Published: (2024-02-01)

Antimicrobial resistance of nosocomial Enterobacteriaceae isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
by: Sukhorukova M.V., et al.
Published: (2017-02-01)

In vitro activity of cefpodoxime against Russian clinical isolates of Haemophilus influenzae, Streptococcus pneumoniae and Streptococcus pyogenes
by: Kozlov R.S., et al.
Published: (2023-12-01)

Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”
by: Sukhorukova M.V., et al.
Published: (2019-10-01)

Detection of aztreonam, meropenem and imipenem resistant Gram negative bacteria from inpatient department in Federal Medical Center (FMC), Birnin, Kebbi, Nigeria
by: Bilyaminu Jega, et al.
Published: (2024-02-01)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
by: Marta Hernández-García, et al.
Published: (2022-10-01)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
by: Nicholas Rebold, et al.
Published: (2023-02-01)

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China
by: Hui Zhang, et al.
Published: (2018-09-01)

Ertapenem Supplemented Selective Media as a New Strategy to Distinguish β-Lactam-Resistant Enterobacterales: Application to Clinical and Wastewater Samples
by: Alexandre Bourles, et al.
Published: (2023-02-01)

Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country
by: Banan M. Aiesh, et al.
Published: (2023-10-01)

Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients
by: A.A. Adegoke, et al.
Published: (2022-07-01)

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020
by: James A. Karlowsky, et al.
Published: (2023-05-01)

Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant Enterobacterales Isolates
by: Jocelyn Qi-Min Teo, et al.
Published: (2023-06-01)

Usage patterns of carbapenem antimicrobials in dogs and cats at a veterinary tertiary care hospital
by: Alison Smith, et al.
Published: (2019-07-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non-Burn Patients in Tehran
by: Zahra Ghareboghy Sarmad, et al.
Published: (2015-09-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non Burn Patients in Tehran
by: Zahra Ghareboghy-Sarmad, et al.
Published: (2015-11-01)

Detection of carbapenemase-producing Enterobacterales by means of matrix-assisted laser desorption ionization time-of-flight mass spectrometry with ertapenem susceptibility-testing disks as source of carbapenem substrate
by: Elvira R. Shaidullina, et al.
Published: (2022-11-01)

In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales
by: Zhiwei Huang, et al.
Published: (2024-04-01)

In vitro activity of thiamphenicol against Haemophilus influenzae, Streptococcus pneumoniae and Streptococcus pyogenes clinical isolates
by: Ivanchik N.V., et al.
Published: (2021-04-01)